Balindres, Baby Girl .
HRN: 24-58-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2024
CEFUROXIME 750MG (VIAL)
02/19/2024
02/26/2024
IV
310mg
Q8
T/C UTI; URTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes